Evidence map›Paper›PMID 42840444›Full record

ArticleIJID regions2026

Risk factors associated with the development of multidrug-resistant bloodstream infection in patients with colonization: a case-control retrospective study.

Jinan Al Jadeedi, Majada Allouyahi, Rouya Al Busaidi, Shatha Al Riyami, Abdullah Balkhair

Abstract read
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinan Al JadeediCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Majada AllouyahiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Rouya Al BusaidiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Shatha Al RiyamiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Abdullah BalkhairInfectious Diseases Unit, Department of Medicine, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To examine the risk factors associated with the development of multidrug-resistant organism (MDRO) bloodstream infection (BSI) in hospitalized adult patients with previous MDRO colonization or isolation from clinical samples. Methods: This retrospective, matched case-control study compared patients with previous MDRO colonization or isolation from clinical samples who developed BSI with patients with the same MDRO species who did not develop BSI. Factors associated with the progression from previous MDRO isolation to BSI were examined using conditional logistic regression, stratified by the matched set. Matching was performed at 1:2 according to age and sex. Results: A total of 1269 non-repeat previous MDRO isolation events were identified in 961 patients. A total of 12.9% of patients had two or more MDROs isolates. Overall, 172 (13.5%) non-repeat BSI events occurred in patients with MDRO colonization/infection, of which 78 (45.4%) were caused by the same MDRO species. A total of 6.1% of previous MDRO isolation events progressed to BSI caused by the same MDRO species. Previous admission to the intensive care unit (adjusted odds ratio 4.31; 95% confidence interval 1.44-12.96; Conclusion: Recent intensive care unit admission and central venous catheterization are independently associated with progression from previous MDRO isolation to BSI.

Indexed as

Bloodstream infectionColonizationMultidrug-resistant organismsOman

Identifiers

PMID42840444
PMCPMC13639158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.